A Safety and Efficacy of CCRT With Paclitaxel/Carboplatin as Adjuvant Therapy to Post-operative Cervical Cancer Patients
PHASE2CompletedINTERVENTIONAL
Enrollment
55
Participants
Timeline
Start Date
August 31, 2004
Conditions
Cervical Cancer
Interventions
DRUG
paclitaxel, carboplatin
Trial Locations (1)
110-744
Seoul National University Hospital, Seoul
All Listed Sponsors
lead
Korean Gynecologic Oncology Group
OTHER
NCT00340184 - A Safety and Efficacy of CCRT With Paclitaxel/Carboplatin as Adjuvant Therapy to Post-operative Cervical Cancer Patients | Biotech Hunter | Biotech Hunter